EI
FOMX

EAM Investors’s Foamix Pharmaceuticals Ltd. Ordinary Shares FOMX Stock Holding History

EAM Investors’s Portfolio FOMX Stock Details FOMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-218,200
Closed -$1.6M – 378
2015
Q3 		$1.6M Sell
218,200
-42,961
-16% -$438K 0.25% 194
2015
Q2 		$2.68M Buy
+261,161
New +$2.89M 0.31% 150

Other funds holding FOMX

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
SAM
Senzar Asset Management New York $34.7M AUM 0.56% 1-Year Est. Return
DA
DSC Advisors Chicago, Illinois $11M AUM 5.88% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

EAM Investors's FOMX Position: Q4 2015 in Review

EAM Investors sold out of Foamix Pharmaceuticals Ltd. Ordinary Shares (FOMX) in Q4 2015, closing a stake of 218,200 shares — an estimated $1.6M sold.

EAM Investors first reported a position in FOMX in Q2 2015 and held it in 2 quarters. The position peaked at $2.68M in Q2 2015. 72 funds tracked by Wall St. Rank hold FOMX as of Q4 2015.

  • EAM Investors reported no remaining Foamix Pharmaceuticals Ltd. Ordinary Shares position as of Q4 2015 after selling out during the quarter.
  • EAM Investors sold 218,200 Foamix Pharmaceuticals Ltd. Ordinary Shares shares in Q4 2015, an estimated $1.6M.
  • EAM Investors first reported a position in Foamix Pharmaceuticals Ltd. Ordinary Shares in Q2 2015 and held it in 2 quarters.
  • EAM Investors's Foamix Pharmaceuticals Ltd. Ordinary Shares position peaked at $2.68M in Q2 2015.
  • 72 funds tracked by Wall St. Rank held Foamix Pharmaceuticals Ltd. Ordinary Shares as of Q4 2015.

Based on EAM Investors's 13F filing for Q4 2015, filed 5 Feb 2016.